Digital China Participates in $17 Million Funding for UK's Congenica

23:21 EDT 30 Apr 2019 | ChinaBio Today

Digital China Health Technologies participated in a $17.1 million extension of a Congenica Series B funding that has now raised a total of $30 million. Congenica, a UK company, is developing the next generation of its Sapientia™ platform, an AI decision support system for genomics used to identify rare diseases and provide cancer management. Last year, DCHealth acquired rights to promote the Sapientia platform in China. DCHealth is the healthcare subsidiary of Digital China Holdings, a major China IT company. More details....

Stock Symbol: (HK: 00861)

Share this with colleagues:

Original Article: Digital China Participates in $17 Million Funding for UK's Congenica


More From BioPortfolio on "Digital China Participates in $17 Million Funding for UK's Congenica"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...